Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.

Ophthalmology
Jordi MonésJeffrey S Heier

Abstract

An independent Safety Review Committee (SRC), supported by Novartis Pharma AG, analyzed investigator-reported cases of intraocular inflammation (IOI), endophthalmitis, and retinal arterial occlusion in the phase 3 HAWK and HARRIER trials of brolucizumab versus aflibercept in neovascular age-related macular degeneration (nAMD). A post hoc analysis of a subset of data from two 2-year, double-masked, multicenter, active-controlled randomized phase 3 trials (NCT02307682, NCT02434328). Patients (N = 1817) with untreated, active choroidal neovascularization due to age-related macular degeneration in the study eye were randomized and treated in HAWK/HARRIER. The SRC reviewed data from cases of investigator-reported IOI (60/1088 brolucizumab-treated eyes; 8/729 aflibercept-treated eyes). The SRC received details and images (color fundus photography, fluorescein angiography, and OCT) for all investigator-determined cases of IOI, retinal arterial occlusion, and endophthalmitis. Cases were reviewed in detail by ≥2 readers, then adjudicated by the SRC as a group. Within this patient subset: incidence of IOI, signs and incidence of retinal vasculitis and/or retinal vascular occlusion, and visual acuity loss; time since first brolucizumab in...Continue Reading

References

Nov 1, 1984·Archives of Ophthalmology·F L FerrisL Hyman
Apr 30, 2011·The New England Journal of Medicine·UNKNOWN CATT Research GroupGlenn J Jaffe
Jan 19, 2016·Nature Reviews. Drug Discovery·Napoleone Ferrara, Anthony P Adamis
Oct 19, 2017·Ophthalmology Retina·UNKNOWN Bevacizumab-Ranibizumab International Trials Group
Aug 14, 2018·The British Journal of Ophthalmology·Sumit Randhir SinghUNKNOWN Ziv-aflibercept Study Group
Apr 14, 2020·American Journal of Ophthalmology Case Reports·Atul JainQuan Dong Nguyen

❮ Previous
Next ❯

Citations

Jan 21, 2021·Expert Opinion on Investigational Drugs·Massimo NicolòCarlo Enrico Traverso
Feb 9, 2021·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·F G HolzU Pleyer
Feb 18, 2021·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·L J KesslerR Khoramnia
Feb 24, 2021·ACS Chemical Biology·Paul S MarinecSachdev S Sidhu
Feb 26, 2021·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·N KaupkeM Casagrande
Mar 17, 2021·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ichiro MarukoUNKNOWN Japan AMD Research Consortium
Apr 4, 2021·Journal of Clinical Medicine·Jacob T CoxLucia Sobrin
Apr 14, 2021·Ocular Immunology and Inflammation·Emmett T CunninghamManfred Zierhut
Apr 14, 2021·The British Journal of Ophthalmology·Louisa Maria BulirschFrank G Holz
Apr 22, 2021·Vestnik oftalmologii·A Zh FursovaA S Derbeneva
Apr 27, 2021·Expert Opinion on Biological Therapy·Lorenzo Ferro DesideriMassimo Nicolò
May 9, 2021·International Journal of Retina and Vitreous·William J AndersonGustavo Barreto Melo
May 21, 2021·Ocular Immunology and Inflammation·Ashish SharmaQuan Dong Nguyen
Jun 3, 2021·Journal of Clinical Medicine·Alper BilgicThibaud Mathis
Jul 3, 2021·Journal of Clinical Medicine·Alper BilgicThibaud Mathis
Aug 6, 2021·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·Marius BookD Pauleikhoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.